PRELUDE THERAPEUTICS INC (PRLD) Capital expenditures 2019–2025
PRELUDE THERAPEUTICS INC (PRLD) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$67,000FY2025 · since FY2019: $780,000 → $67,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67,000 | -91.2% |
| FY2024 | $764,000 | -78.3% |
| FY2023 | $3.5M | +16.4% |
| FY2022 | $3.0M | +30.0% |
| FY2021 | $2.3M | +274.1% |
| FY2020 | $621,000 | -20.4% |
| FY2019 | $780,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice